 |
|
Inter-ovarian differences in ultrasound markers of ovarian size in women with polycystic ovary syndrome
Sungwook Chun
Clin Exp Reprod Med. 2019;46(4):197-201. Published online 2019 Nov 19 DOI: https://doi.org/10.5653/cerm.2019.00374
|
|
Citations to this article as recorded by
 Ovarian Morphometric and Histologic Characteristics and Correlation with Clinical Factors: A Cross-Sectional Study
Eirini Giovannopoulou, Maria-Valeria Karakasi, Maria Kouroupi, Argyro-Ioanna Ieronimaki, Eleni Papakonstantinou, Alexandra Giatromanolaki, Panagiotis Tsikouras, Pavlos Pavlidis
Journal of Personalized Medicine.2023; 13(2): 232. CrossRef Fine particulate matter and polycystic ovarian morphology
Victoria Fruh, Jay Jojo Cheng, Ann Aschengrau, Shruthi Mahalingaiah, Kevin J. Lane
Environmental Health.2022;[Epub] CrossRef Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
Graeme L Fraser, Barbara Obermayer-Pietsch, Joop Laven, Georg Griesinger, Axelle Pintiaux, Dirk Timmerman, Bart C J M Fauser, Christopher Lademacher, Jean Combalbert, Hamid R Hoveyda, Steven Ramael
The Journal of Clinical Endocrinology & Metabolism.2021; 106(9): e3519. CrossRef
|